Literature DB >> 15258082

Ginkgo biloba and acetazolamide for acute mountain sickness: exclusion of high risk, low status groups perpetuates discrimination and inequalities.

Jean Adams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15258082      PMCID： PMC478272          DOI： 10.1136/bmj.329.7458.171-b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).

Authors:  Jeffrey H Gertsch; Buddha Basnyat; E William Johnson; Janet Onopa; Peter S Holck
Journal:  BMJ       Date:  2004-03-11
  1 in total
  4 in total

Review 1.  Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs.

Authors:  Víctor H Nieto Estrada; Daniel Molano Franco; Roger David Medina; Alejandro G Gonzalez Garay; Arturo J Martí-Carvajal; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2017-06-27

2.  Interventions for preventing high altitude illness: Part 3. Miscellaneous and non-pharmacological interventions.

Authors:  Daniel Molano Franco; Víctor H Nieto Estrada; Alejandro G Gonzalez Garay; Arturo J Martí-Carvajal; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2019-04-23

Review 3.  Interventions for treating acute high altitude illness.

Authors:  Daniel Simancas-Racines; Ingrid Arevalo-Rodriguez; Dimelza Osorio; Juan Va Franco; Yihan Xu; Ricardo Hidalgo
Journal:  Cochrane Database Syst Rev       Date:  2018-06-30

Review 4.  Interventions for preventing high altitude illness: Part 2. Less commonly-used drugs.

Authors:  Alejandro Gonzalez Garay; Daniel Molano Franco; Víctor H Nieto Estrada; Arturo J Martí-Carvajal; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2018-03-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.